We employ a team of more than 50 highly qualified scientific, engineering and support staff at our facility in Alnwick. Within the scientific groups, 57% hold a BSc (Hons); 21% hold a Master’s degree, and 21% have a PhD. We are a mature, dedicated team of people with an average of 20 years' industry experience that works in partnership with our customers to deliver outstanding results. We pride ourselves on our innovative approach and ensuring a timely and professional response.
Arcinova is led by a highly experienced and competent leadership team, as introduced below.
Your Project Leaders
Isotope Labelling Team Leader
Alan is a PhD Organic Chemist with over 20 years experience in the synthesis of radiolabelled and stable labelled compounds. He has worked for a number of major organisations, including Sanofi, Covance and Wellcome.
Alan completed his PhD at the University of Manchester and subsequently undertook Post Doctoral work at the University of Nottingham with Prof. G. Pattenden.
He has extensive experience of working in a GLP/GMP regulated environment and acts as Site Radiation Protection Supervisor (RPS) with experience in dealing with regulatory bodies such as the Environment Agency (EA).
Head of Quality Assurance
John leads the Quality Assurance activities at ARCINOVA, spanning GCP, GLP and GMP; he has been a member of RQA for over 20 years. John has over 30 years experience in the pharmaceutical industry with global pharmaceutical and contract research organisations, initially in lab-based roles before moving into Quality Assurance.
John is a Life Sciences graduate from Napier University in 1991, with a Certificate in Quality Management from Newcastle College (1995) and a Diploma in Research Quality Assurance from Anglia University (1997).
“Quality is at the heart of everything we do.”
Strategic Program Management & Study Director
Lee is a biologist with 25 years experience of drug development in the pharmaceutical industry. Key roles and responsibilities have included managing a team conducting drug metabolism, exploratory bioanalysis and in vitro biochemical assays. Lee is an experienced Study Director and lead scientist, responsible for the development of new technologies (eg LC-MS metabonomics platform).
Lee is a graduate in Applied Biology from the University of Hertfordshire,
"The great days at work are when we find a way to overcome a client’s challenge and this new insight gives their data meaning and understanding. That’s why it’s easy to become invested in a client project."
Head of Production, GMP Manufacturing
After arriving at the Alnwick site as a formulation scientist, Simon now has over 30 years experience within pharmaceutical R&D formulation development, technical transfer and clinical manufacturing, spanning both “big pharma” and CRO environments. His responsibilities include providing advice to clients with respect to their manufacturing needs.
After graduating in pharmacy from the University of London, Simon completed a PhD in pharmaceutical microbiology from the University of Nottingham.
Simon is a registered pharmacist and is named on ARCINOVA's IMP Manufacturing Authorisation as the Head of Production, responsible for the manufacture and supply of IMPs to the clinic.
“Working in a CRO environment provides the opportunity to work with many people on multiple, fast turnaround projects. The variety and achievement in delivering quality products provides a great intrinsic reward.”
Head of QC
Daniel studied Pharmaceutical Chemistry at Sheffield Hallam University and began his career as an analytical scientist with Merck, Sharp and Dohme. He now has over 15 years’ experience in the pharmaceutical industry working with large multinational companies such as Sanofi-Aventis and Piramal Healthcare.
Previous positions have included Head of Operational Quality and Quality Control for Quantum Pharma, where Daniel gained accreditation from the MHRA for a fully functional GMP laboratory and developed multi-site quality and operational strategies.
Daniel has extensive experience of business improvement, GxP regulations and computerised Systems.
“No matter how good you get you can always get better, and that's the exciting part.”
Scale-up Chemistry Team Leader
Richard has seven years’ experience working in the pharmaceutical industry in both the contract research and contract manufacturing sectors, including over three years’ experience of leading teams in the development of small molecule syntheses to deliver gram to kilogram quantities of API and pharmaceutical intermediates.
He holds a PhD from the University of Nottingham for research undertaken in natural product synthesis and is a member of both the Royal Society of Chemistry and the Society of Chemical Industry.
Richard has a proven track record of new product introduction, from quotation through to product delivery and has led projects incorporating GMP manufacture and coordination of multifunctional project teams.
“Working with experts in their field to develop high quality, safe and efficient routes to complex APIs for drug development, clinical trials and ultimately commercial supply is a hugely rewarding experience.”
Mark is an organic chemist with over 10 years’ experience working in the pharmaceutical and fine chemical industries. He has particular expertise in Process Development and managing the scale-up of technically complex processes from grams to kilograms.
After graduating in Chemistry from the University of Manchester, Mark completed post-graduate studies in total synthesis at the University of Leeds He has extensive experience of working in a cGMP regulated environment and has a particular focus on controlling potential chemical reaction hazards and the management of Process Safety.
“Taking a lab procedure and developing it into one that can produce kilos of high value product safely, efficiently and with consistently high quality, is a challenge that is always enjoyable to address”
MHRA SymposiumThe 2018 MHRA Symposium will be attended by John McRoberts, Head of QA.
MHRA SymposiumDates: 20th NovemberLocation: London, UK
AAPS: PharmSci360This years' PharmSci360 conference will be attended by Masha Kononov, Senior Director Emerging Biotech US.
AAPS: PharmSci360Dates: 4th - 7th NovemberLocation: Washington DC, US
Bio-Europe 2018Bio-Europe autumn conference will be attended by Nathalie Huther, Business Development Manager Europe.
Bio-Europe 2018Dates: 5th - 7th NovemberLocation: Copenhagen, Denmark